Evaluation of the Effect of Comorbidity on the Efficacy and Safety of β-Lactam Antibiotics in Patients with Community-Acquired Pneumonia

• Váldodahkkit: O. V. Muslimova (Dahkki), E. A. Sokova (Dahkki), A. B. Prokofiev (Dahkki), M. V. Zhuravleva (Dahkki), A. V. Shapchenko (Dahkki), T. V. Alexandrova (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», 2022-07-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Lower respiratory tract infections, which include community-acquired pneumonia (CAP), are the most common cause of death among all infectious diseases. The presence of a comorbid pathology in a patient with CAP suggests a possibility of mutual influence and changes in the course of both the underlyi...